BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37995046)

  • 1. Multimorbidity in Rheumatoid Arthritis: Literature Review and Future Directions.
    Katz J; Bartels CM
    Curr Rheumatol Rep; 2024 Jan; 26(1):24-35. PubMed ID: 37995046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive assessment of multimorbidity burden in a population-based cohort of patients with rheumatoid arthritis.
    Crowson CS; Gunderson TM; Dykhoff HJ; Myasoedova E; Atkinson EJ; Kronzer VL; Coffey CM; Davis Iii JM
    RMD Open; 2022 Jan; 8(1):. PubMed ID: 35042730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity: Single center real life results.
    Armagan B; Sari A; Erden A; Kilic L; Erdat EC; Kilickap S; Kiraz S; Bilgen SA; Karadag O; Akdogan A; Ertenli I; Kalyoncu U
    Medicine (Baltimore); 2018 Mar; 97(13):e9930. PubMed ID: 29595700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Multimorbidity Web in rheumatoid arthritis.
    England BR
    Rheumatology (Oxford); 2023 Oct; 62(SI3):SI242-SI251. PubMed ID: 37871922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidities in Patients with Rheumatoid Arthritis and Their Association with Patient-reported Outcomes: Results of Claims Data Linked to Questionnaire Survey.
    Luque Ramos A; Redeker I; Hoffmann F; Callhoff J; Zink A; Albrecht K
    J Rheumatol; 2019 Jun; 46(6):564-571. PubMed ID: 30647170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of comorbidity in rheumatoid arthritis-associated interstitial lung disease: a nested case-cohort study.
    Mena-Vázquez N; Rojas-Gimenez M; Romero-Barco CM; Gandía-Martínez M; Perez-Gómez N; Godoy-Navarrete FJ; Manrique-Arija S; Garcia-Studer A; Calvo-Gutiérrez J; Varela CF; Morales-Garrido P; Pérez PC; Mouriño-Rodriguez C; Añón-Oñate I; Espildora F; Aguilar-Hurtado MC; Redondo R; Conde AH; de Los Ríos RAD; César EC; Velloso-Feijoo ML; Fernández-Nebro A
    Biomed Pharmacother; 2023 Jan; 157():114049. PubMed ID: 36459713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Occurrence of cardiovascular events within a large population of patients affected by rheumatoid arthritis with or without diabetes.].
    Calabria S; Ronconi G; Dondi L; Piccinni C; Pedrini A; Dondi L; Dell'Anno I; Esposito I; Addesi A; Martini N; Maggioni AP
    Recenti Prog Med; 2023 Feb; 114(2):94-109. PubMed ID: 36700719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study.
    Panopoulos S; Tektonidou M; Drosos AA; Liossis SN; Dimitroulas T; Garyfallos A; Sakkas L; Boumpas D; Voulgari PV; Daoussis D; Thomas K; Georgiopoulos G; Vosvotekas G; Vassilopoulos D; Sfikakis PP
    Arthritis Res Ther; 2018 Dec; 20(1):267. PubMed ID: 30514359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimorbidity Burden in Rheumatoid Arthritis: A Population-based Cohort Study.
    Gunderson TM; Myasoedova E; Davis JM; Crowson CS
    J Rheumatol; 2021 Nov; 48(11):1648-1654. PubMed ID: 33589552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimorbidity in rheumatoid arthritis: common mechanistic links and impact and challenges in routine clinical practice.
    Surandran S; Ahmed S; Walton T; Nikiphorou E; Dey M
    Rheumatology (Oxford); 2023 Oct; 62(SI3):SI260-SI270. PubMed ID: 37871920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women's Rheumatoid Arthritis Sequential Study Registry.
    Curtis JR; Weinblatt M; Saag K; Bykerk VP; Furst DE; Fiore S; St John G; Kimura T; Zheng S; Bingham CO; Wright G; Bergman M; Nola K; Charles-Schoeman C; Shadick N
    Arthritis Care Res (Hoboken); 2021 Apr; 73(4):471-480. PubMed ID: 33002337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a "real-life" study.
    Ruscitti P; Di Muzio C; Conforti A; Di Cola I; Pavlych V; Navarini L; Currado D; Biaggi A; Di Donato S; Marino A; Lorusso S; Ursini F; Giacomelli R; Cipriani P
    Medicine (Baltimore); 2023 Apr; 102(14):e33362. PubMed ID: 37026953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of comorbidities on fatigue in rheumatoid arthritis patients: Results from a nurse-led program for comorbidities management (COMEDRA).
    Tournadre A; Pereira B; Gossec L; Soubrier M; Dougados M
    Joint Bone Spine; 2019 Jan; 86(1):55-60. PubMed ID: 30025953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study.
    Panopoulos S; Thomas K; Georgiopoulos G; Boumpas D; Katsiari C; Bertsias G; Drosos AA; Boki K; Dimitroulas T; Garyfallos A; Papagoras C; Katsimbri P; Tziortziotis A; Adamichou C; Kaltsonoudis E; Argyriou E; Vosvotekas G; Sfikakis PP; Vassilopoulos D; Tektonidou MG
    Rheumatology (Oxford); 2021 Jan; 60(1):170-178. PubMed ID: 32596727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of exacerbation of pulmonary comorbidities in patients with rheumatoid arthritis after initiation of abatacept versus TNF inhibitors: A cohort study.
    Kang EH; Jin Y; Desai RJ; Liu J; Sparks JA; Kim SC
    Semin Arthritis Rheum; 2020 Jun; 50(3):401-408. PubMed ID: 31813561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study.
    Bengtsson K; Jacobsson LT; Rydberg B; Kvist G; Torstenson T; Dehlin M; Hilme E; Lindhé A; Wallerstedt SM; Forsblad-d'Elia H
    BMC Musculoskelet Disord; 2016 Dec; 17(1):499. PubMed ID: 27955647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of comorbidity indices and lung diseases in early rheumatoid arthritis: a UK population-based study.
    Nikiphorou E; de Lusignan S; Mallen C; Roberts J; Khavandi K; Bedarida G; Buckley CD; Galloway J; Raza K
    Rheumatology (Oxford); 2020 Jun; 59(6):1296-1305. PubMed ID: 31580449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Multimorbidity Patterns in Rheumatoid Arthritis Through Machine Learning.
    England BR; Yang Y; Roul P; Haas C; Najjar L; Sayles H; Yu F; Sauer BC; Baker JF; Xie F; Michaud K; Curtis JR; Mikuls TR
    Arthritis Care Res (Hoboken); 2023 Feb; 75(2):220-230. PubMed ID: 35588095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update.
    Singh JA; Cameron DR
    J Manag Care Pharm; 2012 May; 18(4 Supp C):S1-18. PubMed ID: 22656072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial Differences in Multimorbidity and Comorbidities in Rheumatoid Arthritis.
    Kronzer VL; Dykhoff HJ; Stevens MA; Myasoedova E; Davis JM; Crowson CS
    Arthritis Care Res (Hoboken); 2023 Jan; 75(1):76-84. PubMed ID: 36094853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.